Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8

Vox Sanguinis

Volumn 102, Issue 3, 2012, Pages 250-257

  Takahashi, D ^a   Fujihara, M ^a   Azuma, H ^a   Wakamoto, S ^a   Sato, S ^a   Kato, T ^a   Ikeda, H ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

Adhesive interaction; Febrile transfusion reaction; HLA Class I alloantibody; Inflammatory cytokine; Platelet monocyte aggregates

Indexed keywords

ALLOANTIBODY; ANTISERUM; HLA ANTIGEN CLASS 2; HUMAN LEUKOCYTE ANTIGEN CLASS 1 ALLOANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 8; P SELECTIN GLYCOPROTEIN LIGAND 1; UNCLASSIFIED DRUG;

ARTICLE; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD PLATELETS; FEMALE; GENE EXPRESSION REGULATION; HLA-A2 ANTIGEN; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; ISOANTIBODIES; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PLATELET AGGREGATION;

EID: 84858296941     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01549.x     Document Type: Article

References (42)

1. Mangano MM, Chambers LA, Kruskall MS: Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. Am J Clin Pathol 1991; 95:733-738
2. Goodnough LT, Riddell J IV, Lazarus H, et al.: Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration. Vox Sang 1993; 65:103-107
3. Heddle NM, Klama L, Singer J, et al.: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331:625-628
4. Heddle NM, Klama L, Meyer R, et al.: A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999; 39:231-238
5. Muylle L, Joos M, Wouters E, et al.: Increased tumor necrosis factor α (TNF α), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF α and IL-6 levels and febrile transfusion reactions. Transfusion 1993; 33:195-199
6. Stack G, Snyder EL: Cytokine generation in stored platelet concentrates. Transfusion 1994; 34:20-25
7. Aye MT, Palmer DS, Giulivi A, et al.: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995; 35:117-124
8. Fujihara M, Takahashi TA, Ogiso C, et al.: Generation of interleukin 8 in stored apheresis platelet concentrates and the preventive effect of prestorage ultraviolet B radiation. Transfusion 1997; 37:468-475
9. Yazer MH, Podlosky L, Clarke G, et al.: The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44:10-15
10. Paglino JC, Pomper GJ, Fisch GS, et al.: Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44:16-24
11. King KE, Shirey RS, Thoman SK, et al.: Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004; 44:25-29
12. Imoto S, Kawamura K, Tokumine Y, et al.: Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay. Transfus Med 2010; 20:95-103
13. Weyrich AS, Lindemann S, Zimmerman GA: The evolving role of platelets in inflammation. J Thromb Haemost 2003; 1:1897-1905
14. Weyrich AS, Zimmerman GA: Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25:489-495
15. Mickelson JK, Lakkis NM, Villarreal-Levy G, et al.: Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 1996; 28:345-353
16. Neumann FJ, Marx N, Gawaz M, et al.: Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997; 95:2387-2394
17. Furman MI, Benoit SE, Barnard MR, et al.: Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31:352-358
18. Furman MI, Barnard MR, Krueger LA, et al.: Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38:1002-1006
19. Joseph JE, Harrison P, Mackie IJ, et al.: Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001; 115:451-459
20. Sarma J, Laan CA, Alam S, et al.: Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105:2166-2171
21. Danese S, Katz JA, Saibeni S, et al.: Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003; 52:1435-1441
22. Irving PM, Macey MG, Shah U, et al.: Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:361-372
23. Harding SA, Sommerfield AJ, Sarma J, et al.: Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 2004; 176:321-325
24. Shoji T, Koyama H, Fukumoto S, et al.: Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients. J Atheroscler Thromb 2005; 12:344-352
25. Ashman N, Macey MG, Fan SL, et al.: Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Nephrol Dial Transplant 2003; 18:2088-2096
26. Weyrich AS, Elstad MR, McEver RP, et al.: Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97:1525-1534
27. Freedman JE, Loscalzo J: Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002; 105:2130-2132
28. Galt SW, Lindemann S, Medd D, et al.: Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2001; 89:509-516
29. Lindemann SW, Weyrich AS, Zimmerman GA: Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells. Trends Cardiovasc Med 2005; 15:9-17
30. Weyrich AS, McIntyre TM, McEver RP, et al.: Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995; 95:2297-2303
31. Mahoney TS, Weyrich AS, Dixon DA, et al.: Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proc Natl Acad Sci USA 2001; 98:10284-10289
32. Christie DJ, Swinehart CD: Human platelet activating antibodies. Semin Thromb Hemost 1992; 18:186-192
33. Christie DJ, Leja DN, Carlson DL, et al.: Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia. J Lab Clin Med 1993; 121:437-443
34. Brandt JT, Julius CJ, Osborne JM, et al.: The mechanism of platelet aggregation induced by HLA-related antibodies. Thromb Haemost 1996; 76:774-779
35. Nishimura M, Mitsunaga S, Juji T: Frozon-stored granulocytes can be used for an immunofluorescence test to detect granulocyte antibodies. Transfusion 2001; 41:1268-1272
36. Shibata Y, Juji T, Nishizawa Y, et al.: Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981; 41:25-31
37. Wakamoto S, Fujihara M, Abe H, et al.: Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on agonist-induced platelet aggregation and RANTES release in vitro. Artif Cells Blood Substit Immobil Biotechnol 2001; 29:191-201
38. Bournazos S, Rennie J, Hart SP, et al.: Monocyte functional responsiveness after PSGL-1-mediated platelet adhesion is dependent on platelet activation status. Arterioscler Thromb Vasc Biol 2008; 28:1491-1498
39. Rinder HM, Bona JL, Rinder CS, et al.: Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78:1730-1737
40. Haserück N, Erl W, Pandey D, et al.: The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2003; 103:2585-2592
41. Huo Y, Schober A, Forlow SB, et al.: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9:61-67
42. Michelson AD, Barnard MR, Krueger LA, et al.: Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104:1533-1537